April 03, 2018
UK study finds using pharmacy care plans (PCPs) to support patients with long-term conditions could reduce healthcare costs by up to 21%
In partnership with researchers at the University of East Anglia, thirty-eight community pharmacies in West Yorkshire took part in a pilot between February 2015 and June 2016 in which pharmacists devised personalized care plans for 378 patients over age 50 with at least one cardiovascular disease or diabetes, and on one or more medicines.
Pharmacy teams used patient activation – as measured by PAM® — as well as goal setting and therapy management to encourage patients to manage their own long-term conditions with regular consultations at a pharmacy over a 12-month period.
According to the report’s authors, moving patients from the lowest to highest level of activation could reduce healthcare costs by up to 21%. The cost-effectiveness of the PCP service was estimated to be £8,495 ($12,050) per “quality adjusted life year” – one year of life in perfect health.
Read the full study.